pentafluoropropionic anhydride has been researched along with Osteoporosis, Postmenopausal in 1 studies
*Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, MH; Chung, BC; Kim, KJ; Moon, JY; Moon, MH | 1 |
1 other study(ies) available for pentafluoropropionic anhydride and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
A novel GC-MS method in urinary estrogen analysis from postmenopausal women with osteoporosis.
Topics: Bone and Bones; Estrogens; Ethyl Ethers; Female; Fluorocarbons; Gas Chromatography-Mass Spectrometry; Gonadal Steroid Hormones; Humans; Middle Aged; Osteoporosis, Postmenopausal | 2011 |